Literature DB >> 34097726

Recovery From COVID-19-Related Olfactory Disorders and Quality of Life: Insights From an Observational Online Study.

Camille Ferdenzi1, Christophe Bousquet1, Pierre-Emmanuel Aguera1, Morgane Dantec1, Christelle Daudé1, Lesly Fornoni1, Arnaud Fournel1, Aurélien Kassan1, Marylou Mantel1, Maëlle Moranges1, Erwan Moussy1, Stéphane Richard Ortegón1, Catherine Rouby1, Moustafa Bensafi1.   

Abstract

Although olfactory disorders (OD) are among the most significant symptoms of COVID-19, recovery time from COVID-19-related OD and their consequences on the quality of life remain poorly documented. We investigated the characteristics and behavioral consequences of COVID-19-related OD using a large-scale study involving 3111 French respondents (78% women) to an online questionnaire over a period of 9 months covering different epidemic waves (from 8 April 2020 to 13 January 2021). In the patients who subjectively recovered from COVID-19-related OD (N = 609), recovery occurred on average after 16 days and most of the time within 1 month ("normal" recovery range); 49 subjectively recovered in 1-2.5 months, and several cases took up to 6.5 months. Among the patients with ongoing OD (N = 2502), 974 were outside the "normal" recovery range (persistent OD) and reported OD for 1-10 months. Developing a persistent OD was more likely with increasing age and in women and was more often associated with parosmia and phantosmia. The deleterious impact of COVID-19-related OD on the quality of life was significantly aggravated by OD duration and was more pronounced in women. Because persistent OD is not infrequent after COVID-19, has deleterious consequences on the quality of life, and receives few solutions from the health practitioners, it would be beneficial to implement screening and treatment programs to minimize the long-term behavioral consequences of COVID-19-related OD.
© The Author(s) 2021. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  COVID-19; mental health; quality of life; self-report; smell loss

Year:  2021        PMID: 34097726     DOI: 10.1093/chemse/bjab028

Source DB:  PubMed          Journal:  Chem Senses        ISSN: 0379-864X            Impact factor:   3.160


  3 in total

1.  Qualitative Olfactory Dysfunction and COVID-19: An Evidence-Based Review with Recommendations for the Clinician.

Authors:  Joseph B Gary; Liam Gallagher; Paule V Joseph; Danielle Reed; David A Gudis; Jonathan B Overdevest
Journal:  Am J Rhinol Allergy       Date:  2022-08-11       Impact factor: 2.300

2.  Phantom smells: a prevalent COVID-19 symptom that progressively sets in.

Authors:  Christophe Bousquet; Kamar Bouchoucha; Moustafa Bensafi; Camille Ferdenzi
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-09-29       Impact factor: 3.236

3.  Your Money or Your Sense of Smell? A Comparative Analysis of the Sensory and Psychological Value of Olfaction.

Authors:  Rachel S Herz; Martha R Bajec
Journal:  Brain Sci       Date:  2022-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.